Feed Insights Top Reports Pricing

⌘K

17:11:54·1817d

SECFilingvia Quantisnow

SEC Form 10-Q filed by CryoPort, Inc.

ByQuantisnow·Wall Street's wire, on your screen.

CYRX· CryoPort Inc.

Health Care

Original source

This insight was delivered by Quantisnow - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CYRX (CryoPort Inc.) and more on Quantisnow.

Quantisnowquantisnow.com

Quantisnow streams SEC filings, FDA approvals, analyst ratings, insider trades, and press releases to retail investors in real time. This insight was curated and delivered from the Quantisnow live feed.

Companies

CYRX
CryoPort Inc.
Health Care

Recent analyst ratings

Aug 6UpdateKeyBanc Capital Markets-
Aug 6UpdateLeerink Partners$16.00
Jul 22UpdateStephens$13.00
Mar 24UpdateUBS$10.00
Dec 19UpdateGuggenheim$11.00
Dec 19UpdateCanaccord Genuity$11.00

Related

INSIDER4d
President, CEO Shelton Jerrell exercised 104,007 shares at a strike of $1.87, increasing direct ownership by 9% to 1,230,614 units (SEC Form 4)
SEC5d
SEC Form DEFA14A filed by CryoPort Inc.
SEC5d
SEC Form DEF 14A filed by CryoPort Inc.
PR7d
Cryoport to Report First Quarter 2026 Financial Results on May 4, 2026
INSIDER19d
SEC Form 4 filed by Shelton Jerrell
SEC32d
Amendment: SEC Form SCHEDULE 13G/A filed by CryoPort Inc.
INSIDER33d
SEC Form 4 filed by Stefanovich Robert
INSIDER33d
SEC Form 4 filed by Shelton Jerrell

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releases Analyst ratings Insider trading FDA SEC RSS feeds Follow on Google News

Top lists

Trending By market cap Active companies Insider purchases FDA approvals Short volume screener Sectors Market reports

Browse

By event category By exchange Earnings calendar Dividend tracker Insider tracker IPO calendar Compare stocks

Publish

Publish an article Amend a newsitem Pricing Guidelines Terms

Company

About Pricing Refer a trader25%Publish with us Contact

Legal

Terms of use Privacy policy Cookie policy

© 2026 quantisnow.com · Democratizing insights since 2022